Document
IPR2017-01910, No. 1099-99 Exhibit - Ford, Parenteral Products, Pharmaceutics The Science of Dosage Form Design 359 80 Aulton ed, 1988 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1099-99 Exhibit - Ford, Parenteral Products, Pharmaceutics The Science of Dosage Form Design 359 80 Aulton ed, 1988 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1070-70 Exhibit - Neubauer, Changes in Tumour Biological Markers during Primary Systemic Chemotherapy PST, 28 ANTICANCER RESEARCH 1797 804 2008 (P.T.A.B. Au...
Cite Document
IPR2017-01910, No. 1070-70 Exhibit - Neubauer, Changes in Tumour Biological Markers during Primary Systemic Chemotherapy PST, 28 ANTICANCER RESEARCH 1797 804 2008 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1061-61 Exhibit - Thomas, The Effects of ICI 182,780, a Pure Anti Oestrogen, on the Hypothalamic Pituitary Gonadal Axis and on Endometrial Proliferation in Pre Menopaus...
Cite Document
IPR2017-01910, No. 1061-61 Exhibit - Thomas, The Effects of ICI 182,780, a Pure Anti Oestrogen, on the Hypothalamic Pituitary Gonadal Axis and on Endometrial Proliferation in Pre Menopausal Women, 9 H
+ More Snippets
Document
IPR2017-01910, No. 1110-110 Exhibit - Ting, Solubility of Naproxen in Supercritical Carbon Dioxide with and without Cosolvents, 32 IND ENG CHEM RES 1471 81 1993 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1110-110 Exhibit - Ting, Solubility of Naproxen in Supercritical Carbon Dioxide with and without Cosolvents, 32 IND ENG CHEM RES 1471 81 1993 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1009-9 Exhibit - ORegan et al, Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth, 90 J NATL CANCER INST 1552 1558 19...
Cite Document
IPR2017-01910, No. 1009-9 Exhibit - ORegan et al, Effects of the Antiestrogens Tamoxifen, Toremifene, and ICI 182,780 on Endometrial Cancer Growth, 90 J NATL CANCER INST 1552 1558 1998 (P.T.A.B. Aug.
+ More Snippets
Document
IPR2017-01910, No. 1083-83 Exhibit - Baselga, Phase II Study of Weekly Intravenous Recombinant Humanized Anti p185HER2 Monoclonal Antibody in Patients with HER2neu Overexpressing M...
Cite Document
IPR2017-01910, No. 1083-83 Exhibit - Baselga, Phase II Study of Weekly Intravenous Recombinant Humanized Anti p185HER2 Monoclonal Antibody in Patients with HER2neu Overexpressing Metastatic Breast Can
+ More Snippets
Document
IPR2017-01910, No. 1023-23 Exhibit - Qiu, Developing Solid Oral Dosage Forms Pharmaceutical Theory and Practice 2009 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1023-23 Exhibit - Qiu, Developing Solid Oral Dosage Forms Pharmaceutical Theory and Practice 2009 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1092-92 Exhibit - Lee, Standard Deviation and Standard Error of the Mean, 68 KOREAN J ANESTHESIOLOGY 220 23 2015 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1092-92 Exhibit - Lee, Standard Deviation and Standard Error of the Mean, 68 KOREAN J ANESTHESIOLOGY 220 23 2015 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1039-39 Exhibit - Osborne et al, Comparison of the Effects of a Pure Steroidal Antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer, 87 J NATL CANCE...
Cite Document
IPR2017-01910, No. 1039-39 Exhibit - Osborne et al, Comparison of the Effects of a Pure Steroidal Antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer, 87 J NATL CANCER INST 746 750
+ More Snippets
Document
IPR2017-01910, No. 1107-107 Exhibit - Roberts, Investigation of Cosolvent Effects on the Solvation of AOT Reverse Micelles in Supercritical Ethane, 102 J PHYS CHEM B 9074 80 1998 (P.T.A.B...
Cite Document
IPR2017-01910, No. 1107-107 Exhibit - Roberts, Investigation of Cosolvent Effects on the Solvation of AOT Reverse Micelles in Supercritical Ethane, 102 J PHYS CHEM B 9074 80 1998 (P.T.A.B. Aug. 4, 201
+ More Snippets
Document
IPR2017-01910, No. 1080-80 Exhibit - FDAs Inactive Ingredient Database 1996 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1080-80 Exhibit - FDAs Inactive Ingredient Database 1996 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1024-24 Exhibit - Tozer, Introduction to Pharmacokinetics and Pharmacodynamics The Quantitative Basis of Drug Therapy 2006 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1024-24 Exhibit - Tozer, Introduction to Pharmacokinetics and Pharmacodynamics The Quantitative Basis of Drug Therapy 2006 (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1085-85 Exhibit - Goldenberg, Trastuzumab, a Recombinant DNA Derived Humanized Monoclonal Antibody, a Novel Agent for the Treatment of Metastatic Breast Cancer, 21...
Cite Document
IPR2017-01910, No. 1085-85 Exhibit - Goldenberg, Trastuzumab, a Recombinant DNA Derived Humanized Monoclonal Antibody, a Novel Agent for the Treatment of Metastatic Breast Cancer, 21 CLINICAL THERAPEU
+ More Snippets
Document
IPR2017-01910, No. 1003-3 Exhibit - Reserved (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1003-3 Exhibit - Reserved (P.T.A.B. Aug. 4, 2017)
+ More Snippets
Document
IPR2017-01910, No. 1109-109 Exhibit - Simmons, The Laboratory Mouse Selection and Management 127 28 1970 (P.T.A.B. Aug. 4, 2017)
Cite Document
IPR2017-01910, No. 1109-109 Exhibit - Simmons, The Laboratory Mouse Selection and Management 127 28 1970 (P.T.A.B. Aug. 4, 2017)
+ More Snippets